— Know what they know.
Not Investment Advice

NTHI

Neonc Technologies Holdings, Inc.
1W: -6.9% 1M: -29.4% 3M: -18.9% YTD: -21.1%
$5.95
-0.14 (-2.30%)
After Hours: $6.20 (+0.25, +4.20%)
Weekly Expected Move ±10.0%
$6 $7 $7 $8 $9
NASDAQ · Healthcare · Biotechnology · $119.0M · Alpha Radar Strong Sell · Power 32
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$119.0M
52W Range3.2-15.5
Volume98,504
Avg Volume52,349
Beta2.39
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOAmir Farrokh Heshmatpour
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date2025-03-26
8335 Sunset Boulevard
Calabasas, CA 90069
US
310-663-7831
About Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Recent Insider Trades

NameTypeSharesPriceDate
Heshmatpour Amir F P-Purchase 6,000 $6.51 2025-11-24
Heshmatpour Amir F P-Purchase 4,000 $6.50 2025-11-21
Heshmatpour Amir F P-Purchase 20,000 $5.98 2025-11-21
Neman-Ebrahim Yousha P-Purchase 1,100 $6.69 2025-11-20
CHIANG MING-FU (ALAN 0 2025-11-12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms